BLOOD RESEARCH Indexed in /covered by CAS, KoreaScience & DOI/Crossref:eISSN 2288-0011 pISSN 2287-979X

 

Cited by CrossRef (6)

  1. Hyungwoo Cho, Shin Kim, Kyoungmin Lee, Eun Hee Kang, Jung Sun Park, Cheolwon Suh. Single-Center Real-World Experience of Multiple Myeloma in the 21st Century. Korean J Med 2022;97:125
    https://doi.org/10.3904/kjm.2022.97.2.125
  2. Seung Yeon Kim, Sung-Soo Park, Ji-Young Lim, Jung Yeon Lee, Jae-Ho Yoon, Sung-Eun Lee, Ki-Seong Eom, Hee-Je Kim, Chang-Ki Min. Prognostic role of the ratio of natural killer cells to regulatory T cells in patients with multiple myeloma treated with lenalidomide and dexamethasone. Experimental Hematology 2022;110:60
    https://doi.org/10.1016/j.exphem.2022.03.012
  3. A.I. Shikhlyarova, N.Е. Zuderman, N.D. Ushakova, E.M. Frantsiyants, I.А. Goroshinskaya, I.V. Kaplieva, I.V. Neskubina, E.A. Sheiko, I.B. Lysenko. Structural oncomarkers in blood plasma in patients with multiple myeloma when using accompanying selective plasma exchange and chemotherapy. CM 2021:22
    https://doi.org/10.18137/cardiometry.2021.20.2128
  4. Qian Li, Linhui Hu, Alice Charwudzi, Weiwei Zhu, Ye Meng, Zhimin Zhai. Prognostic value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography at diagnosis in untreated multiple myeloma patients: a systematic review and meta-analysis. Clin Exp Med 2022
    https://doi.org/10.1007/s10238-021-00775-z
  5. José-Ángel Hernández-Rivas, Mario Arnao, José Maria Arguiñano Pérez, Araceli Rubio, Esther Gónzalez García, Dunia de Miguel, Dasha Cherepanov, Dorothy Romanus, Katharina Verleger, Courtney Johnson, Shelby L Corman, Marta Grande, Ernesto Pérez Persona. Treatment patterns and outcomes among nontransplant newly diagnosed multiple myeloma patients in Spain. Future Oncology 2021;17:3465
    https://doi.org/10.2217/fon-2021-0301
  6. Xianquan Zhan, Miaolong Lu. Ubiquitin - Proteasome Pathway. 2021.
    https://doi.org/10.5772/intechopen.93586